Carlo
PeopleProgramsSpecialtiesInstitutionsPricing
Sign inJoin waitlistJoin the waitlist
Carlo

the ai that helps you match

Part of the Carlo family
© 2026 Carlo Finance, Inc.
PeopleProgramsSpecialtiesInstitutionsPricingMethodologyPrivacyTerms
Back to overview

University Hospitals Cleveland Medical Center Hematopathology

Fellowship · Cleveland, OH

Sponsored by Case Western Reserve University/University Hospitals Cleveland Medical Center

Research

Works by its people
281
Authors
20
First-author works
45
Citations
7,042
20112026

Topics

  • Acute Myeloid Leukemia Research 19
  • Lymphoma Diagnosis and Treatment 19
  • Hematopoietic Stem Cell Transplantation 13
  • Chronic Lymphocytic Leukemia Research 11
  • Cutaneous lymphoproliferative disorders research 10
  • Brain Metastases and Treatment 8
  • Epilepsy research and treatment 7
  • Viral-associated cancers and disorders 7
  • Acute Lymphoblastic Leukemia research 6
  • Chronic Myeloid Leukemia Treatments 5
  • HIV Research and Treatment 4
  • Immune Cell Function and Interaction 4

Most cited

  1. Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.

    Diabetes & metabolism · 2021 · 93 citations · Zijian Wang

  2. Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment.

    Communications biology · 2023 · 59 citations · Stacey O'Neill

  3. Assessment of a large language model's utility in helping pathology professionals answer general knowledge pathology questions.

    American journal of clinical pathology · 2024 · 14 citations · Joshua Wodskow

  4. Review and Updates on Systemic Mastocytosis and Related Entities.

    Cancers · 2023 · 23 citations · Chris Ryder

  5. Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.

    Blood cancer journal · 2024 · 24 citations · Chen Zhao

  6. SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis.

    Molecular oncology · 2021 · 54 citations · Stacey O'Neill

  7. Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer.

    Cancer research · 2021 · 55 citations · Stacey O'Neill

  8. XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53-mutated myeloid malignancies.

    Blood · 2025 · 10 citations · Chris Ryder